LOGIN
Parathyroid Hormone effective in fracture prevention in postmenopausal osteoporotic women
August 2013
Parathyroid Hormone effective in fracture prevention in postmenopausal osteoporotic women
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Randomized Trial
Ann Intern Med. 2007 Mar 6;146(5):326-39Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
2679 post menopausal women with osteoporosis were randomly assigned to receive either an injection of a parathyroid hormone (PTH), or a placebo, to examine the safety and efficacy of a PTH injection. The results at 18 months, indicated that PTH was successful in reducing the risk for first fracture in those who had no prevalent fracture, as well as reducing additional fracture risk in women who ha...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.